CoChat
Sign Up
Cited by 265Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesNicotinic Acetylcholine Receptors Study

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Efficacy of a Nicotine Lozenge for Smoking Cessation

Shiffman, Saul, Dresler, Carolyn M., Hajek, Peter, Gilburt, Simon J. A., Targett, Darren A., Strahs, Kenneth R.·2002·Archives of Internal Medicine
DOI 10.1001/archinte.162.11.1267
Open this paper in CoChat — free account

Abstract

BACKGROUND: Since nicotine gum was introduced in the 1980s, nicotine replacement therapy has become the most widely used pharmacological smoking cessation treatment. Some smokers prefer acute oral forms, but many smokers reject chewing gum. We tested the safety and efficacy of a new nicotine polacrilex lozenge for smoking cessation. METHODS: Double-blind, placebo-controlled, randomized clinical trial with parallel arms testing 2- and 4-mg nicotine lozenges. Smokers (n = 1818) were assigned to a lozenge dose on the basis of nicotine dependence, assessed by time to the first cigarette of the day. Low-dependence smokers were randomized to receive the 2-mg nicotine (n = 459) or placebo (n = 458) lozenge; high-dependence smokers, the 4-mg nicotine (n = 450) or placebo (n = 451) lozenge. We assessed abstinence at 6, 12, 24, and 52 weeks and analyzed craving and withdrawal symptoms. RESULTS: Treatment with the nicotine lozenge resulted in significantly greater 28-day abstinence at 6 weeks, for the 2-mg (46.0% vs. 29.7%; odds ratio [OR], 2.10; 95% confidence interval [CI], 1.59-2.79; P<.001) and the 4-mg (48.7% vs. 20.8%; OR, 3.69; 95% CI, 2.74-4.96; P<.001) lozenges, compared with placebo. Significant treatment effects were maintained for a full year. Smokers who used more lozenges achieved significantly better treatment effects. Use of the active lozenge also resulted in reduced craving and withdrawal. Most adverse events were moderate and resembled those seen with nicotine gum. CONCLUSION: The nicotine lozenge is a safe and effective new treatment for smoking cessation in low- and high-dependence smokers.

Overview

Integrity signals

Registry

Crossref · 10.1001/archinte.162.11.1267

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

Sorted by citations

Items 201–263 of 263

Related

See all

Metadata

Authors
Shiffman, S., Dresler, C. M., Hajek, P., Gilburt, S. J. A., Targett, D. A., & Strahs, K. R.
Affiliations
Pinney Associates (United States) (US)
ORCID
Shiffman, Saul
Venue
Archives of Internal Medicine
Publisher
American Medical Association (AMA)
Published
2002-06-10
Volume
162
Issue
11
Pages
1267
ISSN
0003-9926 (ISSN-L)
DOI
10.1001/archinte.162.11.1267
OpenAlex
W2132992773
Cited by
265
References
34
Citations by year
2025: 6 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 7 · 2015: 5 · 2014: 9 · 2013: 10 · 2012: 13
FWCI
11.02
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • GlaxoSmithKline
  • University of Pittsburgh
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords
nicotine lozenges, smoking cessation, nicotine replacement therapy, nicotine dependence, abstinence, craving, withdrawal symptoms, nicotine gum, adverse events
MeSH terms
Adult, Double-Blind Method, Female, Humans, Male, Middle Aged, Nicotine, Polymethacrylic Acids, Polyvinyls, Tablets, Smoking Cessation, Tobacco Use Cessation Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review